MedTrace Logo

Study of Colonization of Strains L.Plantarum and L.Brevis in the Product AB-DENTALAC Chewing Gum

NCT03540498 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-12-18

No results posted yet for this study

Summary

Study will follow a randomized, double-blind, placebo-controlled design with two groups in parallel,N of 40 patients in 6 weeks of follow up for the evaluation of two different posology models (daily consumption of probiotic gum, with or without previous professional oral cleaning). Probiotics have recently been used to combat oral diseases (plaque control, caries, halitosis, etc.), as a non-invasive natural therapy.

Conditions

  • Periodontal Disease

Interventions

DIETARY_SUPPLEMENT

AB-DENTALAC [Probiotics (study)]

Treatment for 6 weeks, which will consist of the consumption of a chewing gum AB-DENTALAC with 100mg L.plantarum + L.brevis Probiotics blend (5E+8 CFU each at the end of shelf life), b.i.d (morning and evening).

DIETARY_SUPPLEMENT

Placebo (control)

Treatment for 6 weeks, which will consist of the consumption of a chewing gum placebo, without probiotics strains, b.i.d (morning and evening).

Sponsors & Collaborators

  • Clínica Odontológica Nart en Barcelona

    collaborator UNKNOWN

  • AB Biotics, SA

    lead INDUSTRY

Principal Investigators

  • Jordi Espadaler Mazo, PhD · AB Biotics, SA

  • Jose Nart Molina, DMD · Clínica Odontológica Nart en Barcelona

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-13
Primary Completion
2016-11-24
Completion
2017-02-27

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03540498 on ClinicalTrials.gov